In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Katherine L HebertDepartment of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0002-7221-1857 Sarah B KnopfDepartment of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0002-4654-7074 Thomas ChengDepartment of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Megan C BenzDepartment of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Bridgette M Collins-BurowDepartment of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Jorge A BelgodereDepartment of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0003-3399-4796 Frank H LauDepartment of Medicine, Tulane University, New Orleans, LA 70112, USA.
Elizabeth C MartinDepartment of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Matthew E BurowDepartment of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0002-0642-6630 Van H BarnesDepartment of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0002-1561-0915 Funding
CTSA K12 Program at the University of Alabama at BirminghamK12TR004769 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Renee A. Heffron, Lucio Miele · 2024 to 2026
$4.8MNRSA Training CoreTL1TR003106 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAAG, KENNETH G · 2019 to 2023
$3.7MInterdisciplinary Predoctoral Training in BioinnovationT32EB027632 · NIBIB · TULANE UNIVERSITY OF LOUISIANA · PI GAVER, DONALD P. · 2019 to 2023
$813kNCATS NIH HHS K12 TR004769NCATS NIH HHS TL1TR003106NIBIB NIH HHS T32 EB027632
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
epithelial to mesenchymal transitionERK5extracellular matrixmacrophysiological modelMAPK
Identifiers
PMID41681849
PMCPMC12896816
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390